Russell C. Clark
Analyst · Bhavan Suri, William Blair & Company
Thanks, Jim, and good afternoon everyone. As I review the numbers, all figures quoted are on a GAAP basis unless specifically noted as non-GAAP. We provided a full reconciliation from GAAP to non-GAAP, along the earnings release on our website. For the third quarter of fiscal 2012, revenue totaled $3.2 million compared to total revenue of $3 million for the year-ago period. Of that total, approximately $2.5 million was software and $698,000 was maintenance and professional services. Of the deals completed during the third quarter, 4 were reorders. Cost of revenue in Q3 was $359,000 and about evenly split between the software and maintenance and PS categories. This compares to $438,000 in the year-ago period. Gross margins for Q3 were 89% compared to 85% in the year-ago period. Total operating expenses were $4.8 million compared to $2.2 million in the year-ago period, and included $831,000 of noncash, stock compensation expense compared to $362,000 in the year-ago period. Now let me break down the expenses by category. Selling and marketing expenses were $1.1 million in Q3, compared to $668,000 in the year-ago period. R&D expenses were $2.1 million in Q3, compared to $738,000 in the year-ago period. The year-over-year increase in R&D expenses reflects our continued investment in developing new products. G&A expenses were $1.6 million in Q3 compared to $785,000 in the year-ago period. Our headcount at the end of Q3 remained around 50, and our hiring this year has been primarily focused in the R&D area. GAAP net loss was $2 million or $0.08 per share in the third quarter. This compares to net income of $325,000 or $0.01 per diluted share in the year-ago period. Non-GAAP net loss was $1.2 million or $0.05 per share, compared to net income of $687,000 or $0.03 per diluted share in the year-ago period. Non-GAAP net income excludes stock-based compensation expense and noncash interest and amortization expense related to convertible debt. Our share count for Q3 was 25.6 million basic and fully diluted shares. Turning now to the balance sheet. As of June 30, 2012, we had cash, cash equivalents and investments of $15.4 million, compared to $16.3 million at September 30, 2011. During the first 9 months of fiscal 2012, we've used around $1 million of cash to fund our operating activities, and we believe that our current capital resources are sufficient to fund our business plan. Accounts receivable was $3.2 million, as of the end of Q3, versus $3 million at September 30, 2011. With that, I'll ask the operator to please open the line for questions.